BiomX Inc. HLSQ
0.53
0.00
0.00%
as of 25 Sep
- Market cap
- $1.5M
- P/E
- 0.0×
Follow HLSQ
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(589.93%) | 502.21% | 698.92% | (781.27%) | |
| (76.15%) | (147.70%) | (194.99%) | (137.13%) | ||
ROIC |
(979.68%) | 0.00% | 0.00% | (112.08%) | |
Return on Tangible Assets |
(493.98%) | 4,502.36% | (8,000.00%) | 592.65% | |
Average Days of Receivables |
— | — | — | 0.00 | |
Free Cash Flow per Share |
(170.62) | (161.14) | (88.68) | (17.55) | |
Free Cash Flow |
(28.19) | (26.28) | (23.09) | (18.10) | |
Capital Expenditures |
0.11 | 0.11 | — | 0.06 | |
Piotroski F-Score |
— | — | — | 2.00 | |
| Other line items | |||||
Cash ROIC |
(153.82%) | (722.42%) | (8,045.99%) | (92.91%) | |
Accounts Receivable Turnover |
— | — | — | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.58 | |
Inventory Turnover |
— | — | — | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 370.72 | |
Days of Inventory on Hand |
— | — | — | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.86 | 0.73 | 0.48 | 0.40 | |
Depreciation/Fixed assets |
0.90 | 0.00 | — | 26.64 | |
Capex/Depreciation |
0.04 | 0.04 | — | 0.02 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(171.27) | (161.80) | (88.68) | (17.60) | |
Capex per Share |
0.64 | 0.66 | 0.00 | 0.05 | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates